; or (B) section 351 of the Public Health Service Act ( 42 U.S.C. 262 ). (2) Sunset Paragraph (1) shall cease to be effective on the date that is 10 years after the date of enactment of this subsection. 2. X-prize for vaccine for opioid, cocaine, methamphetamine, or alcohol use disorder (a) Eligible new drug sponsor In this section, the term eligible new drug sponsor means the sponsor of a vaccine to prevent, treat, or mitigate an opioid use disorder (including such a disorder related to fentanyl), a cocaine use disorder, a methamphetamine use disorder, or an alcohol use disorder that— (1) is approved under section 505 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355 ) or is licensed under section 351 of the Public Health Service Act ( 42 U.S.C. 262 ); and (2) is mass-produced. (b) Application An eligible new drug sponsor may submit to the Secretary of Health and Human Services an application for an award, to be known as the Vaccine X–Prize. (c) Award Subject to subsection (d), if the Secretary of Health and Human Services determines that an eligible new drug sponsor has submitted an application under subsection (b), the Secretary shall, subject to the availability of appropriations, pay the eligible new drug sponsor $1,000,000,000. (d) Single award The Secretary of Health and Human Services may not award more than 1 Vaccine X–Prize.